Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fate Therapeutics Inc (NASDAQ:FATE)

6.90
Delayed Data
As of 3:59pm ET
 -0.16 / -2.27%
Today’s Change
3.50
Today|||52-Week Range
8.78
+37.18%
Year-to-Date

Today’s Trading

Previous close7.06
Today’s open7.06
Day’s range6.71 - 7.46
Volume129,448
Average volume (3 months)186,268
Market cap$188.1M
Dividend yield--
Data as of 3:59pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+64.12%
Earnings growth (this year)-12.01%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.12

Competitors

 Today’s
change
Today’s
% change
PSTIPluristem Therapeuti...-0.06-2.51%
SZYMSolazyme Inc-0.06-2.56%
ASTAsterias Biotherapeu...-0.06-1.22%
ENZYEnzymotec Ltd-0.18-2.22%
Data as of 4:01pm ET, 08/03/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$25.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts